Tag: Pharmaceutical
PAOG Confirms CBD Nutraceutical Q4 Revenue Plans
Sandusky, OH, May 11, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to introduce three CBD Nutraceutical Products beginning in the fourth quarter of this year, 2021. On Friday, PAOG released a preview of the company’s plan to launch a CBD Nutraceuticals line of products. PAOG’s CBD
PAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This Friday
Sandusky, OH, May 3, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today announced plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive
PAOG Anticipates Boost To CBD Pharmaceutical Research Initiative From Improving Cannabis Legalization Outlook
Sandusky, OH, April 28, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today highlighted recent cannabis legalization progress anticipated to enhance PAOG’s ongoing CBD Pharmaceutical Development Program. PAOG has partnered with Puration, Inc. (OTC Pink: PURA) to build a pharmaceutical grade indoor hemp grow facility and CBD extraction facility in
Nutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon
Nutra Pharma is announcing their newest product, Luxury Feet; is now available for purchase on Amazon.com Plantation, Florida, April 15, 2021 — OTC PR WIRE — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing
PAOG Announces Opportunity To Expand CBD Pharmaceutical Research
Sandusky, OH, April 13, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived
SIBANNAC, INC. ANNOUNCES ENTRY INTO MEMORANDUM OF UNDERSTANDING TO ACQUIRE STELLAR CHEMICAL CORP.
Scottsdale, Arizona, April 12, 2021 – OTC PR WIRE – Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following: Sibannac, Inc. and Stellar Chemical Corp. (“Stellar”), a New Jersey based nutraceutical and industrial chemical manufacturer, have entered into a Memorandum of Understanding for Sibannac to acquire 51% of Stellar in
PAOG Advances CBD Pharmaceutical Developments Backed By US Patent
Sandusky, OH, April 8, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is
PAOG Targets September 2021 To Introduce CBD Nutraceuticals To Market Co-Packed By ALKM and Marketed Through USMJ
Sandusky, OH, March 16, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today released details on the company’s nutraceutical developments initiative following last week’s introduction of adding CBD RELAX-RX to existing CBD RespRx developments. The details today are highlighted by the company’s September 2021 go-to-market target date with nutraceutical co-packing
Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels
Nutra Pharma is announcing the marketing and distribution plans for Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettos Plantation, Florida, March 16, 2021 — OTC PR WIRE — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine
PURA and PAOG Confirm Ongoing And Expanding Cannabis Partnership
Dallas, TX, March 11, 2021 – Puration, Inc. (OTC Pink: PURA) and PAOG Group, Inc. (OTC Pink: PAOG) today confirmed the two companies continue to work together on developing a variety of cannabis centric applications through a partnership that initiated when PAOG acquired PURA’s cannabis cultivation business last year. The PURA and
Recent Posts
Archives
Categories
- Aerospace
- Agriculture
- Aircraft
- Alternative Energy
- ALYI
- Apparel
- Applications
- Arts
- AUTOMOTIVE
- Autoparts
- Banking
- Barchart
- Basketball
- Beauty Products
- Benzinga
- Beverage
- Biotechnology
- Bitcoin
- Blockchain
- Branding
- Building Material
- CANNABIS
- CBD
- Cloud
- Coffee
- Communication
- Construction
- Consumer
- Corporate
- COVID_19
- COVID-19
- Crew Management
- CRM
- Cryptocurrency
- CSE
- Digital
- Digital Currency
- ECommerce
- EDM MEDIA
- EIN Newswire
- Electric Vehicles
- Energy
- Entertainment
- Environment
- Events
- Export
- Fashion
- Featured
- Film
- Financial
- Fintech
- Fitness
- Fleet Management
- Food
- Food for thought
- Frozen Food
- Ftiness
- Fuel
- GALENFEHA
- Gaming
- GEGR
- Gold
- Government
- GPS Tracking
- Healthcare
- HEMP
- ICO
- IMTL
- INSIDER FINANCIAL
- Insurance
- Internet
- Investingcom
- Investment
- Investor Relations
- IoT
- Jewelry
- Lifestyle
- Logistic
- Manufacturing
- Marijuana
- Marketing
- Media
- Medical
- Merger & Acquisition
- Mining
- Moodys
- Motorcycle
- NASDAQ
- Network
- Newsroom
- NFT
- Nutrition
- NYSE
- Oil & Gas
- Online
- OTC Markets
- OTCQB
- OTT
- PAOG
- Pet
- Pharmaceutical
- Precious Metals
- Psychedelic Mushroom
- Public Relations
- Publicity
- QMedia
- Quote
- Rare Earth
- Real Estate
- Renewable Energy
- Renovable Energy
- Rental
- Retail
- RF Components
- RLTR
- SaaS
- Science
- Security
- SFIN
- Shareholders
- Shipping
- Skincare
- Social Media
- Software
- Solar Energy
- Spirits
- Sports
- SSET
- Staffing
- Streaming
- Supplements
- Tech
- Telecommunication
- Television
- Tequila
- Transportation
- UCIX
- Uncategorized
- Video Post
- VR
- Waste Treatment
- Water Treatment
- Wellness
- Wind Power
Contact Us
- 707-OTC-WIRE (707-682-9473)
- cs@otcprwire.com
Recent Comments